Louis G D'Alecy Selected Research

dimethylarginine

1/2020	Enhanced dimethylarginine degradation improves coronary flow reserve and exercise tolerance in Duchenne muscular dystrophy carrier mice.
6/2012	Nitric oxide synthase, ADMA, SDMA, and nitric oxide activity in the paraventricular nucleus throughout the etiology of renal wrap hypertension.
12/2011	Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase.
2/2009	Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease.
1/2006	Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Louis G D'Alecy Research Topics

Disease

3	Hypertension (High Blood Pressure) 06/2012 - 10/2005
3	Ischemia 09/2008 - 02/2002
2	Malnutrition (Nutritional Deficiencies) 01/2021 - 09/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2011 - 02/2009
2	Acidosis 05/2009 - 02/2006
2	Hypotension (Low Blood Pressure) 04/2009 - 03/2007
2	Hypoxia (Hypoxemia) 09/2008 - 01/2007
2	Body Weight (Weight, Body) 06/2006 - 01/2006
2	Atherosclerosis 06/2004 - 11/2003
1	Exocrine Pancreatic Insufficiency 01/2021
1	Kwashiorkor 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2020
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2020
1	Fatigue 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2020
1	Muscular Dystrophies (Muscular Dystrophy) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 09/2015
1	Erythropoietic Protoporphyria 09/2015
1	Porphyrias (Porphyria) 09/2015
1	Heart Failure 09/2012
1	Thrombosis (Thrombus) 04/2011
1	Respiratory Acidosis 05/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2009
1	Kidney Diseases (Kidney Disease) 02/2009
1	Fabry Disease (Fabry's Disease) 10/2008
1	Insulin Resistance 03/2007
1	Lipodystrophy 03/2007
1	Renal Insufficiency (Renal Failure) 01/2006
1	Neoplasms (Cancer) 09/2004
1	Chronic Renal Insufficiency 11/2003
1	Pancreatitis 09/2003
1	Hyperemia 07/2003
1	Abdominal Aortic Aneurysm 02/2002

Drug/Important Bio-Agent (IBA)

5	dimethylarginineIBA 01/2020 - 01/2006
5	Proteins (Proteins, Gene)FDA Link 09/2015 - 09/2003
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 11/2003
4	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 09/2012 - 11/2003
4	Nitric Oxide Synthase (NO Synthase)IBA 06/2012 - 10/2005
2	salicylhydroxamic acid (SHAM)IBA 06/2012 - 01/2007
2	Troponin IIBA 05/2009 - 02/2006
2	PPAR gammaIBA 04/2009 - 03/2007
2	Oxygen (Dioxygen)IBA 09/2008 - 01/2007
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	EnzymesIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	dimethylargininaseIBA 01/2020
1	Arginine (L-Arginine)FDA Link 01/2020
1	DystrophinIBA 01/2020
1	Pharmaceutical PreparationsIBA 09/2015
1	Deferoxamine (Desferal)FDA LinkGeneric 09/2015
1	Chelating AgentsIBA 09/2015
1	AcidsIBA 09/2015
1	PorphyrinsIBA 09/2015
1	protoporphyrin IXIBA 09/2015
1	IronIBA 09/2015
1	symmetric dimethylarginineIBA 06/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2012
1	arginine methyl esterIBA 06/2012
1	Peroxidase (Myeloperoxidase)IBA 12/2011
1	lysosomal Pro-X carboxypeptidaseIBA 04/2011
1	CalciumIBA 05/2009
1	esmolol (Brevibloc)FDA LinkGeneric 05/2009
1	Histidine (L-Histidine)FDA Link 05/2009
1	Adrenergic Agents (Adrenergic Drugs)IBA 05/2009
1	alpha-Galactosidase (Beano)IBA 10/2008
1	Proline (L-Proline)FDA Link 09/2008
1	SaltsIBA 03/2007
1	KetonesIBA 01/2007
1	camostatIBA 06/2006
1	Sirolimus (Rapamycin)FDA Link 06/2006
1	Protein Isoforms (Isoforms)IBA 02/2006
1	SodiumIBA 01/2006
1	Urea (Carbamide)FDA LinkGeneric 01/2006
1	CreatinineIBA 01/2006
1	PotassiumIBA 01/2006
1	NitrogenIBA 01/2006
1	Vasoconstrictor AgentsIBA 10/2005
1	Phenylalanine (L-Phenylalanine)FDA Link 09/2004
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2003
1	Vitamin E FDA LinkGeneric 11/2003
1	CeruletideIBA 09/2003
1	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 09/2003
1	Eukaryotic Initiation Factor-4F (EIF4F)IBA 09/2003
1	NitritesIBA 02/2002
1	Nitroglycerin (Dynamite)FDA LinkGeneric 02/2002

Therapy/Procedure

1	Therapeutics 01/2020
1	Lasers (Laser) 07/2003